SMC May Update

May 13, 2008 at 9:09 am | In Prescribing Extra - Drugs | Print SMC May Update Print | No Comments

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Aliskiren (Rasilez®) has been rejected for the treatment of essential hypertension. Escitalopram (Cipralex®) has been rejected for the treatment of social anxiety disorder. Both rejections we made because the manufacturers failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Email Delicious Digg Facebook Google+ reddit StumbleUpon Twitter
Copyright ©2008 Prescribing Advice for GPs
« »

No Comments yet »

RSS feed for comments on this post. TrackBack URI

Leave a comment





XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS Feed for New Entries.
Akismet has protected Prescribing Advice for GPs from 378,231 spam comments.